Myriad Genetics | MYGN - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Agilent USD 408M 44M 2026-03
Becton, Dickinson and Co. USD 39M 354M 2026-03
Bio-Rad Laboratories USD 542.1M 1.23B 2026-06
Bruker USD 117M 95.1M 2026-06
Danaher USD 1.08B 157M 2026-06
Illumina USD 260M 103M 2026-06
J&J USD 8.66B 839M 2026-06
Mettler Toledo International USD 209.66M 119.42M 2026-03
Myriad Genetics USD 4.6M 3.4M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Quidel USD -79.5M 32.9M 2026-03
Repligen USD 14.15M 12.38M 2026-06
Revvity USD 187.24M 137.25M 2026-06
Standard Biotools USD -14.62M 7.42M 2026-03
Thermo Fisher Scientific USD 1.73B 389M 2026-03
Veracyte USD 26.52M 3.45M 2026-06
Waters USD 356M 444M 2026-06